Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 805 results for "alexion pharmaceuticals"

Alexion Pharma Purchases Synageva Biopharma
Pharmaceutical Manufacturing Magazine

EMA Endorses Alexion's Strensiq to Treat Rare Bone Disease

The European Medicines Agency recommended under exceptional circumstances Alexion Pharmaceutical's Strensiq for the long-term treatment of hypophosphatasia, a rare metabolic disorder that weakens bones. Strensiq (asfotase alfa), the first ... FDA News, 4 hours ago
[x]  

40 images for alexion pharmaceuticals

Jutia Group, 6 days ago
Drug Discovery and Development, 5 days ago
InsiderMonkey.com, 2 days ago
European Pharmaceutical Review, 1 week ago
Jutia Group, 4 weeks ago
American Banking News, 1 month ago
TheStreet.com, 1 week ago
Forbes.com, 6 days ago
Forbes.com, 6 days ago
Forbes.com, 6 days ago
Ticker Report

Alexion Pharmaceuticals Receives Overweight Rating from Barclays (ALXN)

Barclays restated their overweight rating on shares of Alexion Pharmaceuticals (NASDAQ:ALXN) in a research note issued to investors on Thursday, Market Beat reports. The firm currently has a $205.00 price target on the biopharmaceutical company's ...
 SleekMoney6 hours ago Analysts Ratings Reiterations for July, 2nd (ALXN, BAX, BERY, C, CAM, CMCSA, CX, ESRX, FB, FOXA)  Ticker Report14 hours ago Alexion Pharmaceuticals's Overweight Rating Reaffirmed at Barclays (ALXN)  Ticker Report15 hours ago Sanford C. Bernstein Reiterates $267.00″ Price Target for Alexion Pharmaceuticals (ALXN)  SleekMoney1 week ago
[x]  

SmarTrend Watching for Potential Rebound in Shares of Alexion Pharmaceuticals After 3.63% Loss

(Comtex SmarTrend(R)) Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $177.38 to a high of $183.55. Yesterday, the shares fell 3.6%, which took the trading range below the 3-day low of $181.86 on volume ...
 Individual.com3 days ago SmarTrend Watching for Potential Pullback in Shares of Alexion Pharmaceuticals After 2.59% Gain  Individual.com2 weeks ago Alexion Pharmaceuticals Set to Possibly Pullback After Yesterday's Rally of 6.82%  Individual.com3 weeks ago
[x]  
InsiderMonkey.com

What The Smart Money Thinks Of Barclays Top Healthcare Picks: Alexion Pharmaceuticals, Inc. (ALXN), Baxter International Inc (BAX), & Valeant Pharmaceuticals Intl Inc (VRX)

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) , Baxter International Inc (NYSE: BAX ) , and Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) are among the top healthcare stock picks of Barclays PLC (ADR) (NYSE: BCS ) in its Americas Top Picks List ...
 InsiderMonkey.com2 days ago
CBC

How pharmaceutical company Alexion set the price of the world's most expensive drug

What if your life depended on a drug that cost half a million dollars a year, every year, for the foreseeable future? That's the price of Soliris, one of the world's most expensive drugs. It is the only medicine available for people suffering from ...
 CBC1 week ago How a pharmaceutical firm priced its life-saving drug at $500K a year  CBC1 week ago

ALEXION PHARMACEUTICALS INC (0000899866) (Reporting)

 SEC Filings3 days ago S-8 - ALEXION PHARMACEUTICALS INC (0000899866) (Filer)  SEC2 days ago S-8 POS - ALEXION PHARMACEUTICALS INC (0000899866) (Filer)  SEC1 week ago 424B3 - ALEXION PHARMACEUTICALS INC (0000899866) (Filer)  SEC2 weeks ago
Jutia Group

Company Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) Europe gives green light to new Novartis, Alexion drugs

[Reuters] New drugs from Novartis and Alexion won a green light from European regulators on Friday, delivering a boost to both drugmakers and offering new treatment options for cancer and rare diseases. . . . → Read More: Similar Articles: Market ...
 Market Pulse Navigator6 days ago Europe gives green light to new Novartis, Alexion drugs  Reuters6 days ago Stock Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) Alexion to Present at Investor Conferences  Vision Monday1 month ago
[x]  

Alexion Pharmaceuticals Makes a Move: Up...

Alexion Pharmaceuticals (NASDAQ:ALXN) is one of today's biggest movers, up 1.8% to $187.70. The Dow is up 0.9% to 18,166 and the S&P is currently up 0.8% to 2,127. In the past 52 weeks, Alexion Pharmaceuticals share prices have been bracketed by ...
 Financial News Network online1 week ago Alexion Pharmaceuticals Shares Climbing Higher, Up 1.2%  Individual.com2 weeks ago Shares of Alexion Pharmaceuticals Receive a Boost, Up 2.0%  Individual.com3 weeks ago

Alexion Pharmaceuticals (ALXN) Showing Bullish Technicals With Resistance At $189.52

MarketIntelligenceCenter.com's patented trade-picking algorithms have identified an attractive covered-call trade on Alexion Pharmaceuticals Inc ( ALXN ). Look at the Aug. '15 $180.00 covered call for a net debit in the $172.75 area. This trade ...
 TradingCharts.com3 days ago Potential Alexion Pharmaceuticals (ALXN) Trade Has 5.38% Downside Protection  TradingCharts.com6 days ago Alexion Pharmaceuticals (ALXN) Trading Near $191.29 Resistance Level  TradingCharts.com1 week ago

Alnylam Reports Data on Potential Alexion Rival Drug

B iotech Alnylam Pharmaceuticals (NASDAQ: ALNY ) reported positive data Friday on a rare-disease drug candidate and potential competitor to Alexion 's (NASDAQ: ALXN ) blockbuster Soliris. The market was underwhelmed, however, and Alnylam stock was ...
 Investor's Business Daily2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - alexion pharmaceuticals
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less